يعرض 1 - 10 نتائج من 683 نتيجة بحث عن '"LYSOSOMAL storage diseases"', وقت الاستعلام: 1.19s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية

    المساهمون: CHU Lille, Institut Pasteur de Lille, Université de Lille, Impact de l'environnement chimique sur la santé humaine - ULR 4483 IMPECS

    وصف الملف: application/rdf+xml; charset=utf-8; application/octet-stream

    العلاقة: Journal of Translational Medicine; J Transl Med; http://hdl.handle.net/20.500.12210/59679Test

  4. 4
    دورية أكاديمية

    المصدر: Current Pediatrics; Том 22, № 6 (2023); 572-576 ; Вопросы современной педиатрии; Том 22, № 6 (2023); 572-576 ; 1682-5535 ; 1682-5527

    وصف الملف: application/pdf

    العلاقة: https://vsp.spr-journal.ru/jour/article/view/3357/1351Test; Schuchman EH, Desnick RJ. Types A and B Niemann-Pick disease. Mol Genet Metab. 2017;120(1-2):27–33. doi: https://doi.org/10.1016/j.ymgme.2016.12.008Test; Beutler E, Grabowski GA. Gaucher disease. In: The Metabolic and Molecular Bases of Inherited Disease. Vol. 3. Scriver CR, Beaudet AL, Sly WS, Valle D, eds. New York: McGraw-Hill: 2001. pp. 3635–3668.; Niemann A. Ein unbekanntes Krankheitsbild. Jahrb Kinderheillkd. 1914;79:1.; Pick L. Über die lipoidzellige splenohepatomegalie typus Niemann-Pick als stoffwechselerkrankung. Med Klin (Munich). 1927; 23:1483–1486.; Niemann-Pick disease In: Genes and Disease [Internet]. National Center for Biotechnology Information (US). Bethesda (MD): National Center for Biotechnology Information (US); 1998. Available online: https://www.ncbi.nlm.nih.gov/books/NBK22176Test. Accessed on December 20, 2023.; Arslan N, Coker M, Gokcay GF, et al. Expert opinion on patient journey, diagnosis and clinical monitoring in acid sphingomyelinase deficiency in Turkey: a pediatric metabolic disease specialist’s perspective. Front Pediatr. 2023;11:1113422. doi: https://doi.org/10.3389/fped.2023.1113422Test; Jones SA, McGovern M, Lidove O, et al. Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy. Mol Genet Metab. 2020;131(1-2):116–123. doi: https://doi.org/10.1016/j.ymgme.2020.06.008Test; Nicholson AG, Florio R, Hansell DM, et al. Pulmonary involvement by Niemann-Pick disease. A report of six cases. Histopathology. 2006;48(5):596–603. doi: https://doi.org/10.1111/j.1365-2559.2006.02355.xTest; Freitas HMP, Mançano AD, Rodrigues RS, et al. Niemann-Pick disease type B: HRCT assessment of pulmonary involvement. J Bras Pneumol. 2017;43(6):451–455. doi: https://doi.org/10.1590/S1806-37562017000000062Test; Iaselli F, Rea G, Cappabianca S, et al. Adult-onset pulmonary involvement in Niemann-Pick disease type B. Monaldi Arch Chest Dis. 2011;75(4):235–240. doi: https://doi.org/10.4081/monaldi.2011.211Test; Ishii H, Takahashi T, Toyono M, et al. Acid sphingomyelinase deficiency: cardiac dysfunction and characteristic findings of the coronary arteries. J Inherit Metab Dis. 2006;29(1):232–234. doi: https://doi.org/10.1007/s10545-006-0226-yTest; Tassoni JP Jr, Fawaz KA, Johnston DE. Cirrhosis and portal hypertension in a patient with adult Niemann-Pick disease. Gastroenterology. 1991;100(2):567–569. doi: https://doi.org/10.1016/0016-5085Test(91)90233-b; Lever AM, Ryder JB. Cor pulmonale in an adult secondary to Niemann-Pick disease. Thorax. 1983;38(11):873–874. doi: https://doi.org/10.1136/thx.38.11.873Test; McGovern MM, Wasserstein MP, Aron A, et al. Ocular manifestations of Niemann-Pick disease type B. Ophthalmology. 2004;111(7): 1424–1427. doi: https://doi.org/10.1016/j.ophtha.2003.10.034Test; Wasserstein M, Godbold J, McGovern M.M. Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B. J Inherit Metab Dis. 2013;36(1):123–127. doi: https://doi.org/10.1007/s10545-012-9503-0Test; Schuchman E.H. The pathogenesis and treatment of acid sphingomyelinase-deficient Niemann–Pick disease. J Inherit Metab Dis. 2007; 30(5):654–663. doi: https://doi.org/10.1007/s10545-007-0632-9Test; Schuchman EH, Wasserstein MP. Types A and B Niemann-Pick disease. Best Pract Res Clin Endocrinol Metab. 2015;29(2):237–247. doi: https://doi.org/10.1016/j.beem.2014.10.002Test; Kingma SD, Bodamer OA, Wijburg FA. Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening. Best Pract Res Clin Endocrinol Metab. 2015;29(2):145–157. doi: https://doi.org/10.1016/j.beem.2014.08.004Test; Prevalence of rare diseases: Bibliographic data. Orphanet Report Series, Rare Diseases collection. 2023 Number 1: Diseases in alphabetical order. Available online: http://www.orpha.net/orphacom/cahiers/docs/GB/Prevalence_of_rare_diseases_by_alphabetical_list.pdfTest. Accessed on December 10, 2023.; Poorthuis HM, Wevers RA, Kleijer WJ, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet. 1999;105(1-2): 151–156. doi: https://doi.org/10.1007/s004399900075Test; McGovern MM, Schuchman EH. Acid sphingomyelinase deficiency. In: Gene Reviews [Internet]. Pagon RA, Bird TC, Dolan CR, Stephens K, eds. Seattle (WA): University of Washington, Seattle; 1993–2006.; Meikle P, Hopwood JJ, Clague AR, et al. Prevalence of lysosomal storage disorders. JAMA. 1999;281(3):249–254. doi: https://doi.org/10.1001/jama.281.3.249Test; McGovern MM, Wasserstein MP, Giugliani R, et al. A prospective, cross-sectional survey study of the natural history of Niemann–Pick disease type B. Pediatrics. 2008;122(2):e341–e349. doi: https://doi.org/10.1542/peds.2007-3016Test; Thurberg BL, Wasserstein MP, Schiano T, et al. Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann–Pick disease type B). Am J Surg Pathol. 2012;36(8): 1234–1246. doi: https://doi.org/10.1097/PAS.0b013e31825793ffTest; Acuna M, Martínez P, Moraga C, et al. Epidemiological, clinical and biochemical characterization of the p.(Ala359Asp) SMPD1 variant causing Niemann–Pick disease type B. Eur J Hum Genet. 2016; 24(2):208–213. doi: https://doi.org/10.1038/ejhg.2015.89Test; Cassiman D, Packman S, Bembi B, et al. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): literature review and report of new cases. Mol Genet Metab. 2016;118(3):206–213. doi: https://doi.org/10.1016/j.ymgme.2016.05.001Test; McGovern MM, Aron A, Brodie SE, et al. Natural history of type A Niemann–Pick disease: possible endpoints for therapeutic trials. Neurology. 2006;66(2):228–232. doi: https://doi.org/10.1212/01.wnl.0000194208.08904.0cTest; McGovern MM, Lippa N, Bagiella E, et al. Morbidity and mortality in type B Niemann–Pick disease. Genet Med. 2013;15(8):618–623. doi: https://doi.org/10.1038/gim.2013.4Test; Faverio P, Stainer A, De Giacomi F, et al. Molecular pathways and respiratory involvement in lysosomal storage diseases. Int J Mol Sci. 2019;20(2):327. doi: https://doi.org/10.3390/ijms20020327Test; Wasserstein M, Dionisi-Vici C, Giugliani R, et al. Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD). Mol Genet Metab. 2019;126(2):98–105. doi: https://doi.org/10.1016/j.ymgme.2018.11.014Test; Volders P, Van Hove J, Lories RJ, et al. Niemann–Pick disease type B: an unusual clinical presentation with multiple vertebral fractures. Am J Med Genet. 2002;109(1):42–51. doi: https://doi.org/10.1002/ajmg.10278Test; McGovern MM, Pohl-Worgall T, Deckelbaum RJ, et al. Lipid abnormalities in children with types A and B Niemann Pick disease. J Pediatr. 2004;145(1):77–81. doi: https://doi.org/10.1016/j.jpeds.2004.02.048Test; Walton DS, Robb RM, Crocker AC. Ocular manifestations of group A Niemann-Pick disease. Am J Ophthalmol. 1978;85(2):174–180. doi: https://doi.org/10.1016/s0002-9394Test(14)75945-8; Libert J, Toussaint D, Guiselings R. Ocular findings in Niemann-Pick disease. Am J Ophthalmol. 1975;80(6):991–1002. doi: https://doi.org/10.1016/0002-9394Test(75)90327-x; Lowe D, Martin F, Sarks J. Ocular manifestations of adult Niemann-Pick disease: a case report. Aust N Z J Ophthalmol. 1986;14(1):41–47. doi: https://doi.org/10.1111/j.1442-9071.1986.tb00006.xTest; Hollak CE, de Sonnaville ES, Cassiman D, et al. Acid sphingomyelinase (Asm) deficiency patients in the Netherlands and Belgium: disease spectrum and natural course in attenuated patients. Mol Genet Metab. 2012; 107(3):526–533. doi: https://doi.org/10.1016/j.ymgme.2012.06.015Test; Geberhiwot T, Wasserstein M, Wanninayake S, et al. Consensus clinical management guidelines for acid sphingomyelinase deficiency (Niemann–Pick disease types A, B and A/B). Orphanet J Rare Dis. 2023;18(1):85. doi: https://doi.org/10.1186/s13023-023-02686-6Test; Harzer K, Rolfs A, Bauer P, et al. Niemann–Pick disease type A and B are clinically but also enzymatically heterogeneous: pitfall in the laboratory diagnosis of sphingomyelinase deficiency associated with the mutation Q292 K. Neuropediatrics. 2003;34(6):301–306. doi: https://doi.org/10.1055/s-2003-44668Test; Mihaylova V, Hantke J, Sinigerska I, et al. Highly variable neural involvement in sphingomyelinase-deficient Niemann–Pick disease caused by an ancestral Gypsy mutation. Brain. 2007;130(Pt 4): 1050–1061. doi: https://doi.org/10.1093/brain/awm026Test; Wasserstein MP, Aron A, Brodie SE, et al. Acid sphingomyelinase deficiency: prevalence and characterization of an intermediate phenotype of Niemann–Pick disease. J Pediatr. 2006;149(4):554–559. doi: https://doi.org/10.1016/j.jpeds.2006.06.034Test; Pavlu-Pereira H, Asfaw B, Poupctová H, et al. Acid sphingo-myelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study. J Inherit Metab Dis. 2005;28(2):203–227. doi: https://doi.org/10.1007/s10545-005-5671-5Test; Imrie J, Mengel KE, Cassiman D, et al. Cause of death in patients with attenuated acid sphingomyelinase deficiency: Comprehensive literature review and report of new cases. Mol Genet Metab. 2016; 117:S60. doi: https://doi.org/10.1016/j.ymgme.2015.12.298Test; Sen Sarma M, Tripathi PR. Natural history and management of liver dysfunction in lysosomal storage disorders. World J Hepatol. 2022; 14(10):1844–1861. doi: https://doi.org/10.4254/wjh.v14.i10.1844Test; https://vsp.spr-journal.ru/jour/article/view/3357Test

  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
    دورية أكاديمية

    المساهمون: Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique (SPCMIB), Institut de Chimie de Toulouse (ICT), Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS)-Institut National Polytechnique (Toulouse) (Toulouse INP), Université de Toulouse (UT)-Institut de Recherche pour le Développement (IRD)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Fédératif de Biologie (IFB), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Laboratoire de chimie de coordination (LCC), Centre de Recherches en Cancérologie de Toulouse (CRCT), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Association "Vaincre les Maladies Lysosomales", Université Paul Sabatier

    المصدر: ISSN: 0947-6539.

  10. 10
    دورية أكاديمية